Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2014
04/08/2014US8691753 Pseudodipeptides as MMP inhibitors
04/08/2014CA2635827C Anthranilamide derivatives and their use for the control of insects and acari
04/08/2014CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
04/03/2014WO2014051939A1 Phenicol antibacterial agents
04/03/2014WO2014050982A1 Novel amine compound and use thereof
04/03/2014WO2014050911A1 Metal complex dye, photoelectric conversion element, dye-sensitized solar cell, dye solution, and dye-adsorbed electrode
04/03/2014WO2014049488A1 Benzamide and heterobenzamide compounds
04/03/2014WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors
04/03/2014WO2014015056A3 Anti-mucus drugs and uses therefor
04/03/2014US20140094610 Process for the preparation of an hiv integrase inhibitor
04/03/2014US20140094609 Process for the preparation of an hiv integrase inhibitor
04/03/2014US20140094489 Heterocyclic carboxylic acid ester derivative
04/03/2014US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors
04/03/2014US20140094450 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
04/02/2014EP2712863A1 Novel inhibitors of bacterial biofilms and related methods
04/02/2014EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
04/02/2014CN103703003A Novel compounds for organic electronic material and organic electroluminescent device using the same
04/02/2014CN103702993A Benzamides
04/02/2014CN103694230A High-purity canagliflozin compound and preparation method thereof
04/02/2014CN103694195A Heterocyclic aromatic micromolecule organic compounds and derivatives, preparation method and medical application
04/02/2014CN102212058B Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
04/02/2014CN102167690B Icariin aglucone derivative and preparation method and application thereof
04/02/2014CN102060841B Acylhydrazone containing heterocyclic amide structure, oxime ester compound and application thereof
04/01/2014US8686152 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1)
04/01/2014US8686134 Ionic liquids
04/01/2014US8686025 Therapeutic lactams
04/01/2014US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
04/01/2014US8685971 Quinolinyloxyphenylsulfonamides
04/01/2014US8685664 Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease
04/01/2014CA2654515C Substituted 3-cyanopyridines as protein kinase inhibitors
04/01/2014CA2628952C Aspartic protease inhibitors
04/01/2014CA2581144C Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
04/01/2014CA2567404C Cyclopenta[b]benzofuran derivatives and the utilization thereof
03/2014
03/27/2014WO2014046495A1 Light-emitting diode having novel structure and electronic apparatus comprising same
03/27/2014WO2014046494A1 Novel compound, and light emitting diode and electronic apparatus comprising same
03/27/2014WO2014046224A1 Coumarin derivative
03/27/2014WO2014044738A1 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
03/27/2014US20140088094 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
03/27/2014US20140088079 Novel diphenylmethane derivatives as sglt2 inhibitors
03/27/2014US20140088046 Phenicol antibacterial agents
03/26/2014CN103687856A A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
03/26/2014CN103666451A Carbazole-thiophene schiff base fluorescent probe compound for detecting and recognizing Fe<3+> and Cr<3+>
03/26/2014CN103664936A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664916A Conjugated micromolecule material based on bithiophene dipyrrole and derivatives thereof, and preparation method and application thereof
03/26/2014CN103664915A Azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording, and inkjet recorded material
03/26/2014CN103664914A Anthracene-containing organic semiconductor material as well as preparation method thereof and organic light-emitting device
03/26/2014CN103664875A Novel method for synthesizing 1,4,5,6-tetrahydropyrimidine derivative
03/26/2014CN103664843A Organic electro-optic chromophore and synthesis method thereof
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN103664737A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN102056905B Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
03/26/2014CN102030737B Clinafloxacin amino derivatives and application thereof
03/26/2014CN101715442B Heterocyclic aspartyl protease inhibitors
03/26/2014CA2828529A1 Azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording, and inkjet recorded material
03/25/2014US8680297 Manufacturing process for tiotropium bromide
03/25/2014US8680138 Organic semiconductors
03/25/2014US8680097 Benzothiophene alkanol piperazine derivatives and their use as antidepressant
03/25/2014US8680092 Nitrogenous heterocyclic compound and medicinal use thereof
03/25/2014US8680091 6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
03/25/2014CA2699989C N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor
03/25/2014CA2623879C Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
03/25/2014CA2620688C Heterocyclic compound
03/25/2014CA2531020C Cannabinoid receptor modulator
03/20/2014WO2014042420A1 A novel organic electroluminescence compound and an organic electroluminescence device containing the same
03/20/2014WO2014042405A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/20/2014WO2014042231A1 Crystal and pharmaceutical preparation containing the same crystal
03/20/2014WO2014041846A1 Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
03/20/2014WO2014041825A1 Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulation
03/20/2014WO2014041708A1 Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
03/20/2014WO2014040243A1 N-substituted phenyl-n'-substituted heterocyclic urea compound and application thereof as anticancer medicament
03/20/2014US20140080891 Fused cyclic compounds
03/20/2014US20140080882 Crystal and pharmaceutical preparation containing the same crystal
03/20/2014US20140080829 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/20/2014US20140080825 Modulators of ATP-binding cassette transporters
03/20/2014US20140080800 Inhibitors of Histone Deacetylase
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080770 Arylalkylamine compound and process for preparing the same
03/20/2014US20140079784 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
03/20/2014US20140079736 Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
03/20/2014US20140077166 Organic compound and organic light emitting device using the same
03/19/2014EP2707366A1 L-proline and citric acid co-crystals of (2s, 3r, 4r, 5s, 6r )- 2- (3- ((5- (4-fluorophenyl)thiophen-2-yl) methyl) -4-methylphenyl)-6- (hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
03/19/2014CN103649079A Hepatitis C inhibitors and uses thereof
03/19/2014CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649073A 17alpha-hydroxylase/c17,20-lyase inhibitors
03/19/2014CN103649070A Processes for the preparation of thietanamine
03/19/2014CN103641822A Canagliflozin compound and pharmaceutical composition thereof
03/19/2014CN103641814A 4'-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/19/2014CN103052632B Dihydropyrazole Compounds
03/18/2014US8674118 Compounds and methods for the treatment or prevention of flavivirus infections
03/18/2014US8674114 Carbazole compound, light-emitting element material, and organic semiconductor material
03/18/2014US8673955 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
03/18/2014US8673178 Liquid crystal medium
03/18/2014CA2780682C 1-heterodiene derivative and pest control agent
03/18/2014CA2621182C 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
03/18/2014CA2619039C 1-acyldihydropyrazole derivatives
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039411A1 Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
03/13/2014WO2014038867A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/13/2014WO2014037480A1 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 523